Charles J Dockendorff Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles J Dockendorff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles J Dockendorff. Charles J Dockendorff is Director in BOSTON SCIENTIFIC CORP ($BSX) and Director in HOLOGIC INC ($HOLX) and Director in HAEMONETICS CORP ($HAE) and EVP & Chief Financial Officer in Covidien plc ($COV) and Director in Keysight Technologies, Inc. ($KEYS).
Latest Insider Trading Transactions of Charles J Dockendorff
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BSX, COV, HAE, HOLX, KEYS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 2,439 | 0 | 39,501 | 37.1 K to 39.5 K (+6.58 %) |
| May 10 2021 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 4,763 | 0 | 37,062 | 32.3 K to 37.1 K (+14.75 %) |
| Mar 23 2021 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 1,631 | 0 | 64,845 | 63.2 K to 64.8 K (+2.58 %) |
| Mar 15 2021 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Option Exercise | A | 71.03 | 5,055 | 359,057 | 5,055 | |
| Mar 15 2021 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Grant | A | 0.00 | 1,478 | 0 | 3,695 | 2.2 K to 3.7 K (+66.67 %) |
| Feb 05 2021 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Option Exercise | M | 35.50 | 12,180 | 432,420 | 0 | |
| Feb 05 2021 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Sell | S | 134.53 | 12,180 | 1,638,575 | 13,755 | 25.9 K to 13.8 K (-46.96 %) |
| Feb 05 2021 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Buy | M | 35.50 | 12,180 | 432,420 | 25,935 | 13.8 K to 25.9 K (+88.55 %) |
| Feb 05 2021 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Option Exercise | M | 35.50 | 12,180 | 432,420 | 0 | |
| Feb 05 2021 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Sell | S | 134.53 | 12,180 | 1,638,575 | 13,755 | 25.9 K to 13.8 K (-46.96 %) |
| Feb 05 2021 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Buy | M | 35.50 | 12,180 | 432,420 | 25,935 | 13.8 K to 25.9 K (+88.55 %) |
| Jul 22 2020 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Grant | A | 0.00 | 1,983 | 0 | 13,755 | 11.8 K to 13.8 K (+16.85 %) |
| May 11 2020 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 5,000 | 0 | 16,099 | 11.1 K to 16.1 K (+45.05 %) |
| May 11 2020 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 5,000 | 0 | 16,099 | 11.1 K to 16.1 K (+45.05 %) |
| Mar 23 2020 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 2,438 | 0 | 63,214 | 60.8 K to 63.2 K (+4.01 %) |
| Mar 09 2020 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Option Exercise | A | 47.36 | 7,322 | 346,770 | 7,322 | |
| Mar 09 2020 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Grant | A | 0.00 | 2,217 | 0 | 22,129 | 19.9 K to 22.1 K (+11.13 %) |
| Jul 26 2019 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Grant | A | 0.00 | 1,460 | 0 | 20,340 | 18.9 K to 20.3 K (+7.73 %) |
| May 13 2019 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 4,990 | 0 | 11,099 | 6.1 K to 11.1 K (+81.68 %) |
| May 13 2019 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 4,990 | 0 | 11,099 | 6.1 K to 11.1 K (+81.68 %) |
| Mar 25 2019 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 2,351 | 0 | 60,776 | 58.4 K to 60.8 K (+4.02 %) |
| Mar 11 2019 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Option Exercise | A | 46.81 | 6,523 | 305,342 | 6,523 | |
| Mar 11 2019 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Grant | A | 0.00 | 2,136 | 0 | 19,912 | 17.8 K to 19.9 K (+12.02 %) |
| Jul 30 2018 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Grant | A | 0.00 | 1,696 | 0 | 18,880 | 17.2 K to 18.9 K (+9.87 %) |
| May 11 2018 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 6,109 | 0 | 63,213 | 57.1 K to 63.2 K (+10.70 %) |
| Mar 26 2018 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 3,897 | 0 | 58,425 | 54.5 K to 58.4 K (+7.15 %) |
| Mar 26 2018 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 780 | 0 | 54,528 | 53.7 K to 54.5 K (+1.45 %) |
| Mar 26 2018 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 1,949 | 0 | 53,749 | 51.8 K to 53.7 K (+3.76 %) |
| Mar 16 2018 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Option Exercise | A | 38.44 | 7,551 | 290,260 | 7,551 | |
| Mar 16 2018 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Buy | P | 38.80 | 13,000 | 504,400 | 17,776 | 4.8 K to 17.8 K (+272.19 %) |
| Mar 16 2018 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Grant | A | 0.00 | 2,406 | 0 | 4,776 | 2.4 K to 4.8 K (+101.52 %) |
| Jul 31 2017 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Grant | A | 39.27 | 4,329 | 170,000 | 17,184 | 12.9 K to 17.2 K (+33.68 %) |
| Jun 13 2017 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Buy | P | 37.81 | 13,210 | 499,470 | 51,800 | 38.6 K to 51.8 K (+34.23 %) |
| May 16 2017 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Option Exercise | A | 43.24 | 5,396 | 233,323 | 5,396 | |
| May 16 2017 | HOLX | HOLOGIC INC | Dockendorff Charles J | Director | Grant | A | 0.00 | 1,747 | 0 | 2,370 | 623 to 2.4 K (+280.42 %) |
| Mar 20 2017 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 39.02 | 4,720 | 184,174 | 38,590 | 33.9 K to 38.6 K (+13.94 %) |
| Mar 20 2017 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 39.02 | 656 | 25,597 | 33,870 | 33.2 K to 33.9 K (+1.98 %) |
| Mar 20 2017 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 39.02 | 2,360 | 92,087 | 33,214 | 30.9 K to 33.2 K (+7.65 %) |
| May 04 2016 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 8,494 | 0 | 50,092 | 41.6 K to 50.1 K (+20.42 %) |
| Mar 21 2016 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 25.98 | 962 | 24,993 | 30,844 | 29.9 K to 30.8 K (+3.22 %) |
| Mar 21 2016 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 25.98 | 3,464 | 89,995 | 29,882 | 26.4 K to 29.9 K (+13.11 %) |
| Mar 21 2016 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 25.98 | 6,928 | 179,989 | 26,417 | 19.5 K to 26.4 K (+35.55 %) |
| Feb 16 2016 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Buy | P | 16.49 | 30,000 | 494,688 | 41,598 | 11.6 K to 41.6 K (+258.67 %) |
| Nov 09 2015 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 38.74 | 656 | 25,413 | 19,489 | 18.8 K to 19.5 K (+3.48 %) |
| Nov 09 2015 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 38.74 | 2,397 | 92,860 | 18,834 | 16.4 K to 18.8 K (+14.58 %) |
| Nov 09 2015 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 35.78 | 1,122 | 40,145 | 16,437 | 15.3 K to 16.4 K (+7.33 %) |
| Jul 23 2015 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Grant | A | 0.00 | 4,337 | 0 | 7,153 | 2.8 K to 7.2 K (+154.01 %) |
| May 07 2015 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 10,650 | 0 | 11,598 | 948 to 11.6 K (+1,123.42 %) |
| May 04 2015 | BSX | BOSTON SCIENTIFIC ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 948 | 0 | 948 | 0 to 948 |
| Mar 23 2015 | KEYS | Keysight Technolog ... | Dockendorff Charles J | Director | Grant | A | 0.00 | 4,793 | 0 | 15,315 | 10.5 K to 15.3 K (+45.55 %) |
| Nov 13 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Grant | A | 0.00 | 254 | 0 | 81,485 | 81.2 K to 81.5 K (+0.31 %) |
| Aug 20 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Buy | P | 39.00 | 2,600 | 101,400 | 81,231 | 78.6 K to 81.2 K (+3.31 %) |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 43.09 | 164,900 | 7,105,178 | 164,900 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 57.10 | 31,359 | 1,790,671 | 31,359 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 55.64 | 31,359 | 1,744,903 | 31,359 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 45.81 | 31,359 | 1,436,581 | 31,359 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 45.66 | 32,457 | 1,481,905 | 32,457 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 41.37 | 20,905 | 864,903 | 20,905 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 38.65 | 47,039 | 1,817,987 | 47,039 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 36.99 | 25,009 | 925,090 | 25,009 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 35.45 | 32,457 | 1,150,708 | 32,457 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 30.40 | 78,399 | 2,383,455 | 78,399 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Option Exercise | A | 18.20 | 39,199 | 713,492 | 39,199 | |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Grant | A | 0.00 | 47,810 | 0 | 78,631 | 30.8 K to 78.6 K (+155.12 %) |
| Jul 03 2007 | COV | Covidien plc | Dockendorff Charles J | EVP & Chief Financi ... | Grant | A | 0.00 | 21,868 | 0 | 30,821 | 9 K to 30.8 K (+244.25 %) |
Page: 1